See more : BYD Electronic (International) Company Limited (BYDIY) Income Statement Analysis – Financial Results
Complete financial analysis of GreenLight Biosciences Holdings (GRNAW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of GreenLight Biosciences Holdings, a leading company in the Biotechnology industry within the Healthcare sector.
- GuiZhou QianYuan Power Co., Ltd. (002039.SZ) Income Statement Analysis – Financial Results
- SK Inc. (034730.KS) Income Statement Analysis – Financial Results
- Questor Technology Inc. (QUTIF) Income Statement Analysis – Financial Results
- An-Shin Food Services Co.,Ltd. (1259.TWO) Income Statement Analysis – Financial Results
- NetSol Technologies, Inc. (NTWK) Income Statement Analysis – Financial Results
GreenLight Biosciences Holdings (GRNAW)
About GreenLight Biosciences Holdings
GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in Medford, Massachusetts.
| Metric | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 6.38M | 0.00 | 962.00K | 3.00M |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 6.38M | 0.00 | 962.00K | 3.00M |
| Gross Profit Ratio | 100.00% | 0.00% | 100.00% | 100.00% |
| Research & Development | 133.81M | 89.83M | 42.87M | 23.49M |
| General & Administrative | 35.93M | 20.32M | 11.17M | 8.71M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 35.93M | 20.32M | 11.17M | 8.71M |
| Other Expenses | -396.00K | -1.60M | -785.00K | 0.00 |
| Operating Expenses | 169.34M | 108.56M | 53.25M | 32.20M |
| Cost & Expenses | 169.34M | 108.56M | 53.25M | 32.20M |
| Interest Income | 895.00K | 37.00K | 83.00K | 865.00K |
| Interest Expense | 4.12M | 2.42M | 1.03M | 317.00K |
| Depreciation & Amortization | 9.93M | 5.81M | 1.84M | 1.55M |
| EBITDA | -153.99M | -102.75M | -50.45M | -27.65M |
| EBITDA Ratio | -2,412.11% | 0.00% | -5,243.97% | -921.33% |
| Operating Income | -163.92M | -108.56M | -52.28M | -29.20M |
| Operating Income Ratio | -2,567.65% | 0.00% | -5,434.93% | -973.08% |
| Total Other Income/Expenses | -2.04M | -3.75M | -967.00K | 553.00K |
| Income Before Tax | -165.96M | -112.31M | -53.25M | -28.65M |
| Income Before Tax Ratio | -2,599.67% | 0.00% | -5,535.45% | -954.65% |
| Income Tax Expense | 1.09M | 2.42M | 1.03M | 317.00K |
| Net Income | -167.06M | -114.73M | -54.28M | -28.97M |
| Net Income Ratio | -2,616.78% | 0.00% | -5,642.31% | -965.21% |
| EPS | -1.27 | -0.93 | -0.56 | -0.30 |
| EPS Diluted | -1.27 | -0.93 | -0.56 | -0.30 |
| Weighted Avg Shares Out | 131.98M | 122.82M | 96.35M | 96.35M |
| Weighted Avg Shares Out (Dil) | 131.98M | 122.82M | 96.35M | 96.35M |
Source: https://incomestatements.info
Category: Stock Reports